Orion, FI0009014377

Jefferies keeps Orion stock at Hold with EUR 77.00 target

Published on 10/15/2026 at 13:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The ODM-216 study reached its first patient on October 5, 2026. Orion stock costs EUR 86.20 on October 15, 2026 at a EUR 12.1 billion market value.

Target and pipeline milestones

  • Jefferies maintained a Hold rating and set a EUR 77.00 target on October 14, 2026.
  • Orion's first patient entered the ODM-216 trial on October 5, 2026.
  • Orion stock traded at EUR 86.20 at 12:53 p.m. CEST at Lang & Schwarz on October 15, 2026.
Schwarzweiß-Reportagefoto von Laborforschern, Orion Oyj FI0009014377
Dokumentarische Schwarzweiß-Reportage zeigt Laborarbeit in Pharmaunternehmen Orion Oyj, ISIN FI0009014377, mit Forschern, Illustration mit AI erstellt.

Orion (ISIN FI0009014377) has a EUR 77.00 price target from Jefferies, which maintained its Hold rating on October 14, 2026, according to Markets Insider. The target puts the current euro quote 11.95 percent above the analyst level.

What does EUR 77 mean?

Orion stock was trading at EUR 86.20 at Lang & Schwarz on October 15, 2026 at 12:53 p.m. CEST. The comparison is important because the target is EUR 9.20 below that quote, despite Jefferies keeping its Hold view.

Orion's latest company profile states that fiscal year 2025 net sales reached EUR 1,890 million and that the group employed about 4,000 people, according to GlobeNewswire. That historical base gives the valuation discussion a concrete operating scale.

Three dated pipeline milestones

On May 30, 2026, Orion disclosed Phase 1/2 results for the TEADES study through its investor-relations materials. On October 5, 2026, the first patient was dosed in the Phase 1/2 BICIDES trial of ODM-216, Orion's first biologic candidate to enter human testing, as GlobeNewswire reported. On October 14, 2026, Jefferies set its EUR 77.00 target while retaining Hold.

When is the next report?

Orion will publish its interim report for January through September 2026 on October 28, 2026, with a webcast scheduled for the same date, according to Placera.se. The report should provide the next dated test of operating performance after the pipeline announcements.

Stock price and valuation

Orion stock was trading at EUR 86.20 at Lang & Schwarz on October 15, 2026 at 12:53 p.m. CEST. Finance data showed a market capitalization of EUR 12.1 billion and a 52-week range of EUR 56.30 to EUR 86.70 as of October 15, 2026.

The further course of trading is shown by the continuously updated real-time quote of Orion stock.

Orion stock facts

  • Company: Orion Corporation
  • ISIN: FI0009014377
  • Ticker: ORNBV.HE
  • Primary exchange: Nasdaq Helsinki
  • Price Lang & Schwarz (as of October 15, 2026, 12:53 p.m. CEST): EUR 86.20
  • Market capitalization: EUR 12.1 billion (as of October 15, 2026)
  • 52-week range: EUR 56.30-EUR 86.70 (as of October 15, 2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: OMX Helsinki 25
  • Next earnings date: October 28, 2026

Market context: Latest market reports.

More news and analyses on Orion stock

Disclaimer...

en | FI0009014377 | ORION | boerse | 70329196 | bgmi